|
|
Gene Symbol |
FBN1 |
|
Aliases |
ACMICD, ECTOL1, FBN, GPHYSD2, MASS, MFLS, MFS1, OCTD, SGS, SSKS, WMS, WMS2 |
|
Entrez Gene ID |
|
|
Gene Name |
Fibrillin 1 |
|
Chromosomal Location |
15q21.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a member of the fibrillin family of proteins. The encoded preproprotein is proteolytically processed to generate two proteins including the extracellular matrix component fibrillin-1 and the protein hormone asprosin. Fibrillin-1 is an extracellular matrix glycoprotein that serves as a structural component of calcium-binding microfibrils. These microfibrils provide force-bearing structural support in elastic and nonelastic connective tissue throughout the body. Asprosin, secreted by white adipose tissue, has been shown to regulate glucose homeostasis. Mutations in this gene are associated with Marfan syndrome and the related MASS phenotype, as well as ectopia lentis syndrome, Weill-Marchesani syndrome, Shprintzen-Goldberg syndrome and neonatal progeroid syndrome. [provided by RefSeq, Apr 2016]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0001501 |
Biological process |
Skeletal system development |
IMP |
8188302 |
GO:0007507 |
Biological process |
Heart development |
IMP |
15781745 |
GO:0033627 |
Biological process |
Cell adhesion mediated by integrin |
IDA |
12807887, 17158881 |
GO:0043010 |
Biological process |
Camera-type eye development |
IEP |
25406291 |
GO:0045671 |
Biological process |
Negative regulation of osteoclast differentiation |
IDA |
24039232 |
GO:0048048 |
Biological process |
Embryonic eye morphogenesis |
IEP |
25406291 |
GO:0048050 |
Biological process |
Post-embryonic eye morphogenesis |
IEP |
25406291 |
GO:2001205 |
Biological process |
Negative regulation of osteoclast development |
IDA |
24039232 |
GO:0001527 |
Cellular component |
Microfibril |
IDA |
1860873, 3536967, 7534784, 8120105, 10424889, 12429738, 22355679 |
GO:0005576 |
Cellular component |
Extracellular region |
HDA |
27068509 |
GO:0005576 |
Cellular component |
Extracellular region |
IDA |
11461921 |
GO:0005604 |
Cellular component |
Basement membrane |
IDA |
3536967 |
GO:0005615 |
Cellular component |
Extracellular space |
HDA |
20551380 |
GO:0005615 |
Cellular component |
Extracellular space |
IDA |
3536967 |
GO:0031012 |
Cellular component |
Extracellular matrix |
IBA |
21873635 |
GO:0031012 |
Cellular component |
Extracellular matrix |
IDA |
3536967 |
GO:0062023 |
Cellular component |
Collagen-containing extracellular matrix |
HDA |
23658023, 23979707, 25037231, 27559042, 28327460, 28675934 |
GO:0062023 |
Cellular component |
Collagen-containing extracellular matrix |
HDA |
20551380 |
GO:0005178 |
Molecular function |
Integrin binding |
IPI |
12807887, 15062093, 17158881 |
GO:0005201 |
Molecular function |
Extracellular matrix structural constituent |
IBA |
21873635 |
GO:0005201 |
Molecular function |
Extracellular matrix structural constituent |
IDA |
3536967 |
GO:0005201 |
Molecular function |
Extracellular matrix structural constituent |
RCA |
20551380, 23979707, 25037231, 27559042, 28327460, 28675934 |
GO:0005509 |
Molecular function |
Calcium ion binding |
IDA |
7691719, 15062093 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
12429738, 15131124, 15165854, 15790312, 17293099, 18339631, 19570982, 21402694, 22355679, 24039232, 25034023, 26601954 |
GO:0008201 |
Molecular function |
Heparin binding |
IDA |
11461921 |
GO:0030023 |
Molecular function |
Extracellular matrix constituent conferring elasticity |
IC |
8120105 |
GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
18448684, 24035709, 25034023 |
GO:0044877 |
Molecular function |
Protein-containing complex binding |
IPI |
15062093 |
|
Protein Information |
|
Protein Name |
Fibrillin-1, asprosin, epididymis secretory sperm binding protein, fibrillin 15, fibrillin-1 preproprotein |
|
Function |
[Fibrillin-1]: Structural component of the 10-12 nm diameter microfibrils of the extracellular matrix, which conveys both structural and regulatory properties to load-bearing connective tissues (PubMed:1860873, PubMed:15062093). Fibrillin-1-containing microfibrils provide long-term force bearing structural support. In tissues such as the lung, blood vessels and skin, microfibrils form the periphery of the elastic fiber, acting as a scaffold for the deposition of elastin. In addition, microfibrils can occur as elastin-independent networks in tissues such as the ciliary zonule, tendon, cornea and glomerulus where they provide tensile strength and have anchoring roles. Fibrillin-1 also plays a key role in tissue homeostasis through specific interactions with growth factors, such as the bone morphogenetic proteins (BMPs), growth and differentiation factors (GDFs) and latent transforming growth factor-beta-binding proteins (LTBPs), cell-surface integrins and other extracellular matrix protein and proteoglycan components (PubMed:27026396). Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively (By similarity). Negatively regulates osteoclastogenesis by binding and sequestering an osteoclast differentiation and activation factor TNFSF11. This leads to disruption of TNFSF11-induced Ca(2+) signaling and impairment of TNFSF11-mediated nuclear translocation and activation of transcription factor NFATC1 which regulates genes important for osteoclast differentiation and function (PubMed:24039232). Mediates cell adhesion via its binding to cell surface receptors integrins ITGAV:ITGB3 and ITGA5:ITGB1 (PubMed:12807887, PubMed:17158881). Binds heparin and this interaction has an important role in the assembly of microfibrils (PubMed:11461921). .; [Asprosin]: Hormone that targets the liver to increase plasma glucose levels. Secreted by white adipose tissue and circulates in the plasma. Acts in response to fasting and promotes blood glucose elevation by binding to the surface of hepatocytes. Promotes hepatocyte glucose release by activating the protein kinase A activity in the liver, resulting in rapid glucose release into the circulation. |
|
|
|
|
|
UniProt |
|
|
PDB |
1APJ, 1EMN, 1EMO, 1LMJ, 1UZJ, 1UZK, 1UZP, 1UZQ, 2M74, 2W86, 5MS9 |
|
|
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Overlap Connective Tissue Disease |
|
Aortic Aneurysm |
|
Aortic Rupture |
|
Aortic root dilatation |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Marfan Syndrome |
9452085, 9338581, 19941982, 11700157, 11826022, 18435798, 7977366, 19533785, 10694921, 8136837, 20803651, 9401003, 16220557, 1301946, 12161601, 15161917, 7738200, 10441597, 15221638, 12402346, 7611299, 7870075, 8040326, 8863159, 8281141, 21542060, 1569206, 16222657, 12203992, 9837823 |
Genetic Diseases |
21594992, 20979188, 17253931, 14598350, 17701892, 25101912, 11700157, 21683322, 16333834, 26026792, 16273536, 12651868, 16571647, 8563763, 23897642, 21594993, 3536967, 20375004, 15241795, 23133647, 24039054, 24635535, 23278365, 25736269, 26787436, 8941093, 25979247, 24665001, 205918 |
Weill-Marchesani syndrome |
|
Ectopia lentis |
25741868, 7802039, 17657824, 22539873, 15054843, 8136837, 17701892, 8188302, 11700157, 12446365, 11826022, 20375004, 12203992, 22772368 |
Arachnodactyly |
|
Skeletal Dysplasia |
|
Pectus Carinatum |
|
Marfan Lipodystrophy Syndrome |
|
Byzanthine arch palate |
|
Wide mouth |
|
Macrocephalus |
|
Contractural Arachnodactyly |
|
Digestive System Diseases |
Liver Cirrhosis |
|
Liver Fibrosis |
|
Endocrine System Diseases |
PCOS |
|
Eye Diseases |
Myopia |
|
Lens Subluxation |
|
Musculoskeletal Diseases |
Stiff Skin Syndrome |
|
Nervous System Diseases |
Brain Aneurysm |
|
Nutritional and Metabolic Diseases |
Hyperinsulinism |
|
Hyperglycemia |
|
Psychiatric/Brain disorders |
Intellectual Disability |
|
Obstructive Sleep Apnea |
|
Reproductive disorders |
Endometriosis |
|
Endometrioma |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
Insulin resistance, Obesity |
|
Rotterdam Criteria |
Indirect
|
41 PCOS Patients and 66 control and 53 T2DM patients |
This study analyzed the potential roles of plasma asprosin in healthy, T2DM, and PCOS females and demonstrated that plasma asprosin increased in patients with PCOS and was associated with various metabolic parameters and sex related hormone profiles. Moreover, blood asprosin might play a vital role in glucose homeostasis, insulin obesity, sex-related hormone metabolism, or inflammation homeostasis, in females with metabolic-related diseases. |
|
|
|
|